| Direct Competitor Comparison | |
|---|
| ARNA | GSK | OREX | RHHBY | Industry |
|---|
| Market Cap: | 1.81B | 128.29B | 610.44M | 223.86B | 71.76B |
|---|
| Employees: | 293 | 99,488 | 41 | 82,089 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.08 | -0.03 | 0.00 | 0.12 | 0.27 |
|---|
| Revenue (ttm):
| 27.77M | 42.21B | 3.43M | 50.83B | 13.93B |
|---|
| Gross Margin (ttm): | 0.54 | 0.71 | N/A | 0.75 | 0.72 |
|---|
| EBITDA (ttm): | -49.30M | 14.49B | -98.88M | 20.10B | 1.51B |
|---|
| Operating Margin (ttm):
| -2.11 | 0.28 | -28.93 | 0.34 | 0.13 |
|---|
| Net Income (ttm): | -77.78M | 6.78B | -99.05M | 10.22B | N/A |
|---|
| EPS (ttm): | -0.37 | 2.74 | -1.29 | 2.99 | 0.61 |
|---|
| P/E (ttm): | N/A | 19.36 | N/A | 22.07 | 18.43 |
|---|
| PEG (5 yr expected): | -2.30 | 4.20 | -0.55 | 2.29 | 1.51 |
|---|
| P/S (ttm): | 63.21 | 3.03 | 178.90 | 4.38 | 3.64 |
|---|
|
| GSK = GlaxoSmithKline plc | | OREX = Orexigen Therapeutics, Inc. | | RHHBY = Roche Holding AG | | Industry = Biotechnology | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.91 | 0.00 | 79.43B | 17.93 |
|---|
| Genentech, Inc. | Private |
|---|
| Biogen Idec Inc. | BIIB | 235.24 | 0.01 | 55.84B | 37.33 |
|---|
| Genzyme Corporation | Private |
|---|
| Merck Serono S.A. | Private |
|---|
| Gilead Sciences Inc. | GILD | 55.81 | 0.01 | 85.13B | 31.25 |
|---|
| MedImmune, L.L.C. | Private |
|---|
| Life Technologies Corporation | LIFE | 74.04 | 0.00 | 12.74B | 31.35 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.34 | -0.00 | 33.52B | 19.64 |
|---|
| Sandoz International GmbH | Private |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 127.23 | -0.01 | 16.25B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private |
|---|
| Mylan, Inc. | MYL | 31.17 | -0.02 | 11.88B | 20.82 |
|---|
| Pfizer Inc. | PFE | 29.04 | -0.00 | 205.99B | 13.90 |
|---|
| Johnson & Johnson | JNJ | 86.82 | -0.00 | 243.87B | 23.58 |
|---|
| GlaxoSmithKline plc | GSK | 52.97 | 0.00 | 128.29B | 19.36 |
|---|
| Sanofi | SNY | 54.86 | 0.01 | 145.20B | 27.04 |
|---|
| Novartis AG | NVS | 74.36 | 0.01 | 182.72B | 18.87 |
|---|
| Roche Holding AG | RHHBY | 65.96 | 0.01 | 223.86B | 22.07 |
|---|
| AstraZeneca PLC | AZN | 52.17 | 0.00 | 65.21B | 11.54 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.76 | 0.01 | 58.86B | 11.51 |
|---|
| Bristol-Myers Squibb Company | BMY | 47.40 | 0.01 | 77.86B | 53.68 |
|---|
|
| News on Direct Competitors | |
|---|
- GSK
- Stalled Progress in the Fight Against HIV? at Motley Fool Sat 8:32am
- OREX
- Nasdaq stocks posting largest percentage decreases AP Fri 6:04pm
- GSK
- Elan Rejects Royalty Offer Again Zacks Fri 3:30pm
- RHHBY
- Shouldn't Money Managers Have to Disclose Their Nestle and Volkswagen Stock, Too? at Barrons.com Fri 2:19pm
- RHHBY
- Why Immunotherapy Stocks Could Be Set for a Big Move at Motley Fool Fri 2:10pm
- RHHBY
- New Diagnostic Solution from Roche Zacks Fri 11:00am
- OREX
- Why This Obesity Drug Is the Sector's Best Bet at Motley Fool Fri 10:27am
- GSK
- Spinning RECORD: Battle Over Rosiglitazone Heats Up Two Weeks Before Crucial FDA Meeting at Forbes Fri 9:46am
- OREX
- Arena - Good Sales, Bad Sales, Long And Short at Seeking Alpha Fri 2:53am
- OREX
- Commit To Purchase Orexigen Therapeutics At $3, Earn 23.3% at TheStreet Thu, May 23
- OREX
- 5 Stocks Under $10 Set to Soar at TheStreet Thu, May 23
- RHHBY
- Wall Street Loves this New Immunotherapy Cancer Drug at Motley Fool Thu, May 23
- RHHBY
- Positive Data on Roche Candidate Zacks Wed, May 22
- GSK
- Glaxo, US partnering to develop new antibiotics AP Wed, May 22
- GSK
- Drugmakers, health groups bring poor girls vaccine AP Thu, May 9
All Headlines for these symbols... Currency in USD. | |
|
1.77%